SARS-CoV-2 infection or vaccination; a trio of tests from EUROIMMUN
EUROIMMUN UK supplies the healthcare industry with medical diagnostic products in the principal areas of autoimmunity, infectious diseases and allergy.
EUROIMMUN UK is the British subsidiary of the EUROIMMUN group, a manufacturer of medical laboratory diagnostic products. EUROIMMUN was one of the first companies in the world to offer a comprehensive panel of SARS-CoV-2 tests, validated for in vitro diagnostic purposes.
Tests offered by EUROIMMUN include direct detection methods and highly accurate indirect detection methods to assess the immune response following SARS-CoV-2 infection or vaccination. The latest assays developed by the company are the Anti-SARS-CoV-2 QuantiVac (IgG), the SARS-CoV-2 NeutraLISA and the SARS-CoV-2 IGRA.
EUROIMMUN UK has supported public health bodies in establishing a serology assay for use in the National Testing Strategy since March 2020, especially for the serosurveillance study, the results of which have informed the UK government’s strategy to combat the pandemic.
www.euroimmun.co.uk
Other News
Featured Supplier
At PerkinElmer we provide scientists, clinicians and governments all across the world with the solutions needed to test, screen and analyze nearly everything on earth, including the earth itself.
We're committed to advancing our health from understanding and finding disease such as cancer sooner, as well as detecting new emerging threats like...
Upcoming Events
Lab Innovations 2021
NEC, Birmingham
3-4 November 2021
IBMS Biomedical Science Congress 2022
International Convention Centre, Birmingham
14-17 March 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
